SHANNON LAUF: Open Payments
NPI 1194455253 · WHEATON, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$571 in 21 payments from 11 companies in 2025. Trend: 2023 $223 · 2024 $0 · 2025 $571
Food & beverage: $571
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $153 |
| ABBVIE INC. | 4 | $91 |
| Otsuka America Pharmaceutical, Inc. | 3 | $69 |
| Collegium Pharmaceutical, Inc. | 2 | $48 |
| Alkermes, Inc. | 2 | $45 |
| Lundbeck LLC | 2 | $43 |
| Corium, LLC | 2 | $34 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $29 |
| Neurocrine BioSciences, Inc. | 1 | $23 |
| Janssen Pharmaceuticals, Inc | 1 | $21 |
Products named: Auvelity, VRAYLAR, REXULTI, Jornay PM, ARISTADA, ABILIFY ASIMTUFII, Azstarys, Sunosi.
Industry payments across IL — which companies pay providers there.
